Home
NUWE
NUWE News

Latest Nuwellis Inc. (NUWE) News on August 23, 2025

MT Newswires

a month ago

Nuwellis Regains Compliance to Trade on Nasdaq

Nuwellis Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference

GlobeNewswire

a month ago

Nuwellis Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference

Nuwellis Regains Compliance with Nasdaq Listing Requirements

GlobeNewswire

a month ago

Nuwellis Regains Compliance with Nasdaq Listing Requirements

JTC Team Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference Now Live

ACCESS Newswire

a month ago

JTC Team Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference Now Live

Nuwellis, Inc. To Report Second Quarter 2025 Financial Results on August 12, 2025

GlobeNewswire

a month ago

Nuwellis, Inc. To Report Second Quarter 2025 Financial Results on August 12, 2025

Nuwellis Announces Closing of $5.0 Million Underwritten Public Offering Including Full Exercise of Overallotment Option

GlobeNewswire

2 months ago

Nuwellis Announces Closing of $5.0 Million Underwritten Public Offering Including Full Exercise of Overallotment Option

Nuwellis announces pricing of $4.3M underwritten public offering

TipRanks

2 months ago

Nuwellis announces pricing of $4.3M underwritten public offering

Nuwellis Announces Pricing of $4.3 Million Underwritten Public Offering

GlobeNewswire

2 months ago

Nuwellis Announces Pricing of $4.3 Million Underwritten Public Offering

Nuwellis Inc (NUWE) Q1 2025 Earnings Call Highlights: Strategic Growth Amidst Operational Challenges

GuruFocus.com

3 months ago

Nuwellis Inc (NUWE) Q1 2025 Earnings Call Highlights: Strategic Growth Amidst Operational Challenges

Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Business Highlights

GlobeNewswire

3 months ago

Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Business Highlights

Nuwellis Expands Aquadex® for Pediatric Fluid Management to Two New Hospital Systems

GlobeNewswire

3 months ago

Nuwellis Expands Aquadex® for Pediatric Fluid Management to Two New Hospital Systems

Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision

GlobeNewswire

4 months ago

Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision

Nuwellis, Inc. To Report First Quarter 2025 Financial Results on May 13, 2025

GlobeNewswire

4 months ago

Nuwellis, Inc. To Report First Quarter 2025 Financial Results on May 13, 2025

Nuwellis Inc (NUWE) Q4 2024 Earnings Call Highlights: Navigating Revenue Challenges with ...

GuruFocus.com

4 months ago

Nuwellis Inc (NUWE) Q4 2024 Earnings Call Highlights: Navigating Revenue Challenges with ...

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire

5 months ago

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results

Nuwellis Announces Retirement of Nestor Jaramillo, Jr. as President and CEO

GlobeNewswire

6 months ago

Nuwellis Announces Retirement of Nestor Jaramillo, Jr. as President and CEO

JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF Study Analysis

GlobeNewswire

6 months ago

JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF Study Analysis

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025

GlobeNewswire

6 months ago

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025

Nuwellis Adds Nationally Ranked Utah Hospital as New Pediatric Customer for Aquadex SmartFlow® Therapy

GlobeNewswire

7 months ago

Nuwellis Adds Nationally Ranked Utah Hospital as New Pediatric Customer for Aquadex SmartFlow® Therapy

Nuwellis Regains Compliance with Nasdaq Listing Requirements

GlobeNewswire

8 months ago

Nuwellis Regains Compliance with Nasdaq Listing Requirements

Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights

GlobeNewswire

9 months ago

Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights

Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds

GlobeNewswire

10 months ago

Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds

Nuwellis Stock Soars 121% on Major Increase in Reimbursement for Aquadex System

GuruFocus.com

10 months ago

Nuwellis Stock Soars 121% on Major Increase in Reimbursement for Aquadex System

Nuwellis Receives Increased Reimbursement Rate for Aquadex SmartFlow® Therapy from the Centers for Medicare and Medicaid

GlobeNewswire

10 months ago

Nuwellis Receives Increased Reimbursement Rate for Aquadex SmartFlow® Therapy from the Centers for Medicare and Medicaid

Nuwellis Announces Preliminary Results for Third Quarter of 2024

GlobeNewswire

10 months ago

Nuwellis Announces Preliminary Results for Third Quarter of 2024

Nuwellis Welcomes University of Iowa Health Care Stead Family Children’s Hospital as Newest Pediatric Customer

GlobeNewswire

10 months ago

Nuwellis Welcomes University of Iowa Health Care Stead Family Children’s Hospital as Newest Pediatric Customer

Nuwellis, Inc. To Report Third Quarter 2024 Financial Results on November 11, 2024

GlobeNewswire

10 months ago

Nuwellis, Inc. To Report Third Quarter 2024 Financial Results on November 11, 2024

Nuwellis to Present at the Third Annual ROTH Healthcare Opportunities Conference

GlobeNewswire

a year ago

Nuwellis to Present at the Third Annual ROTH Healthcare Opportunities Conference

New Study Published in Current Problems in Cardiology Highlights Statistically Significant Reduction in Heart Failure Readmissions at 60 days when using the Aquadex Ultrafiltration Therapy

GlobeNewswire

a year ago

New Study Published in Current Problems in Cardiology Highlights Statistically Significant Reduction in Heart Failure Readmissions at 60 days when using the Aquadex Ultrafiltration Therapy

Nuwellis Announces Pricing of $916,000 Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

GlobeNewswire

a year ago

Nuwellis Announces Pricing of $916,000 Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Nuwellis, Inc. Announces Second Quarter 2024 Financial Results

GlobeNewswire

a year ago

Nuwellis, Inc. Announces Second Quarter 2024 Financial Results

Nasdaq Panel Grants Nuwellis Continued Listing on the Nasdaq Stock Market, Subject to Conditions

GlobeNewswire

a year ago

Nasdaq Panel Grants Nuwellis Continued Listing on the Nasdaq Stock Market, Subject to Conditions

Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s QUELIMMUNE™ Therapy at Cincinnati Children’s

GlobeNewswire

a year ago

Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s QUELIMMUNE™ Therapy at Cincinnati Children’s

Nuwellis Announces Pricing of $2.0 Million Offering Priced At-The-Market Under Nasdaq Rules

GlobeNewswire

a year ago

Nuwellis Announces Pricing of $2.0 Million Offering Priced At-The-Market Under Nasdaq Rules

Nuwellis, Inc. To Report Second Quarter 2024 Financial Results on August 13, 2024

GlobeNewswire

a year ago

Nuwellis, Inc. To Report Second Quarter 2024 Financial Results on August 13, 2024

Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children’s

GlobeNewswire

a year ago

Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children’s

SeaStar Medical Ships First QUELIMMUNE Product Order to U.S. Distribution Partner

GlobeNewswire

a year ago

SeaStar Medical Ships First QUELIMMUNE Product Order to U.S. Distribution Partner

New Evidence on Aquadex Ultrafiltration Therapy to be Presented at HFSA 2024 Conference

GlobeNewswire

a year ago

New Evidence on Aquadex Ultrafiltration Therapy to be Presented at HFSA 2024 Conference

Nuwellis Announces Reverse Stock Split

GlobeNewswire

a year ago

Nuwellis Announces Reverse Stock Split

Nuwellis Secures New Patent for Innovative Pediatric Continuous Renal Replacement Therapy, Vivian™

GlobeNewswire

a year ago

Nuwellis Secures New Patent for Innovative Pediatric Continuous Renal Replacement Therapy, Vivian™

With 58% ownership, Berliner Effektengesellschaft AG (FRA:BFV) insiders have a lot at stake

Simply Wall St.

a year ago

With 58% ownership, Berliner Effektengesellschaft AG (FRA:BFV) insiders have a lot at stake

Better AI Stock: Palantir vs. Snowflake

Motley Fool

a year ago

Better AI Stock: Palantir vs. Snowflake

Is Now the Time to Buy 3 of the S&P 500's Highest-Yielding Dividend Stocks?

Motley Fool

a year ago

Is Now the Time to Buy 3 of the S&P 500's Highest-Yielding Dividend Stocks?

Why We Like The Returns At CTS Eventim KGaA (ETR:EVD)

Simply Wall St.

a year ago

Why We Like The Returns At CTS Eventim KGaA (ETR:EVD)

BigBear.ai Stock: Buy, Sell, or Hold?

Motley Fool

a year ago

BigBear.ai Stock: Buy, Sell, or Hold?

Indonesia's first Olympic gymnast encourages others to 'dream higher'

AFP

a year ago

Indonesia's first Olympic gymnast encourages others to 'dream higher'

Where Will CrowdStrike Stock Be in 1 Year?

Motley Fool

a year ago

Where Will CrowdStrike Stock Be in 1 Year?

Warren Buffett's Strategic Acquisition in Occidental Petroleum Corp

GuruFocus.com

a year ago

Warren Buffett's Strategic Acquisition in Occidental Petroleum Corp

Nuwellis and DaVita Extend Supply and Collaboration Agreement Pilot Phase

GlobeNewswire

a year ago

Nuwellis and DaVita Extend Supply and Collaboration Agreement Pilot Phase

Nuwellis Announces Expansion of Ultrafiltration Program to Pediatric Patients at One of the Largest Hospital Networks in Florida

GlobeNewswire

a year ago

Nuwellis Announces Expansion of Ultrafiltration Program to Pediatric Patients at One of the Largest Hospital Networks in Florida

Nuwellis Announces Purchase Agreement with a 50 Hospital Network for Aquadex Ultrafiltration Therapy

GlobeNewswire

a year ago

Nuwellis Announces Purchase Agreement with a 50 Hospital Network for Aquadex Ultrafiltration Therapy

Nuwellis, Inc. Announces First Quarter 2024 Financial Results

GlobeNewswire

a year ago

Nuwellis, Inc. Announces First Quarter 2024 Financial Results

Nuwellis Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT Technology

GlobeNewswire

a year ago

Nuwellis Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT Technology

Nuwellis Announces Closing of $2.7 Million Public Offering

GlobeNewswire

a year ago

Nuwellis Announces Closing of $2.7 Million Public Offering

Nuwellis, Inc. To Report First Quarter 2024 Financial Results on May 7, 2024

GlobeNewswire

a year ago

Nuwellis, Inc. To Report First Quarter 2024 Financial Results on May 7, 2024

Nuwellis Announces Pricing of $2.7 Million Public Offering

GlobeNewswire

a year ago

Nuwellis Announces Pricing of $2.7 Million Public Offering

Nuwellis Announces Launch of Ultrafiltration Therapy Using Aquadex Smartflow® System at Henry Ford Health

GlobeNewswire

a year ago

Nuwellis Announces Launch of Ultrafiltration Therapy Using Aquadex Smartflow® System at Henry Ford Health

Nuwellis Full Year 2023 Earnings: EPS Beats Expectations

Simply Wall St.

a year ago

Nuwellis Full Year 2023 Earnings: EPS Beats Expectations

Late-Breaking Data Highlighting Benefits of Ultrafiltration Therapy Using the Aquadex System for Heart Failure Patients was Presented at the Technology and Heart Failure Therapeutics Conference

GlobeNewswire

a year ago

Late-Breaking Data Highlighting Benefits of Ultrafiltration Therapy Using the Aquadex System for Heart Failure Patients was Presented at the Technology and Heart Failure Therapeutics Conference

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire

a year ago

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024

GlobeNewswire

a year ago

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024

Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™

GlobeNewswire

2 years ago

Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™

Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

2 years ago

Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Nuwellis to Announce Late-Breaking Clinical Data and Host Satellite Symposium at Technology and Heart Failure Therapeutics Conference

GlobeNewswire

2 years ago

Nuwellis to Announce Late-Breaking Clinical Data and Host Satellite Symposium at Technology and Heart Failure Therapeutics Conference

New Case Series Demonstrates Potential of Aquadex Therapy for End-Stage Liver Disease Patients with Fluid Overload

GlobeNewswire

2 years ago

New Case Series Demonstrates Potential of Aquadex Therapy for End-Stage Liver Disease Patients with Fluid Overload

Soligenix and Mobilicom Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ACCESSWIRE

2 years ago

Soligenix and Mobilicom Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Nortech Systems Expands Fiber Optic Capabilities with Innovative Expanded Beam XtremeTM Technology

Business Wire

2 years ago

Nortech Systems Expands Fiber Optic Capabilities with Innovative Expanded Beam XtremeTM Technology

Air Industries Group Receives Two Strategically Important New Contracts from New Customers

Business Wire

2 years ago

Air Industries Group Receives Two Strategically Important New Contracts from New Customers

Fury Intercepts 31.77 g/t gold and 8.07 g/t Tellurium over 3.5 metres at the Hinge Target

ACCESSWIRE

2 years ago

Fury Intercepts 31.77 g/t gold and 8.07 g/t Tellurium over 3.5 metres at the Hinge Target

Energous Announces Change of Chief Financial Officer

Business Wire

2 years ago

Energous Announces Change of Chief Financial Officer

CPI Aerostructures Appoints Ross Johnson to Leadership Team as Vice President, Program Management

GlobeNewswire

2 years ago

CPI Aerostructures Appoints Ross Johnson to Leadership Team as Vice President, Program Management

Are Consumer Staples Stocks Lagging Coca-Cola HBC (CCHGY) This Year?

Zacks

2 years ago

Are Consumer Staples Stocks Lagging Coca-Cola HBC (CCHGY) This Year?

Nuwellis Receives FDA Clearance for an Additional Dual Lumen Extended Length Peripheral Catheter

GlobeNewswire

2 years ago

Nuwellis Receives FDA Clearance for an Additional Dual Lumen Extended Length Peripheral Catheter

Trust Stamp announces a patent filing for a groundbreaking AI-powered facial recognition technology

GlobeNewswire

2 years ago

Trust Stamp announces a patent filing for a groundbreaking AI-powered facial recognition technology

Air Industries Group Subsidiary Sterling Engineering Corporation Receives $3.2M in New Contracts

Business Wire

2 years ago

Air Industries Group Subsidiary Sterling Engineering Corporation Receives $3.2M in New Contracts

Reasons Why A. O. Smith (AOS) Should be in Your Portfolio Now

Zacks

2 years ago

Reasons Why A. O. Smith (AOS) Should be in Your Portfolio Now

Trust Stamp has partnered with Scurid to deliver highly secure, AI-powered in-field authentication for seamless human-machine interaction

GlobeNewswire

2 years ago

Trust Stamp has partnered with Scurid to deliver highly secure, AI-powered in-field authentication for seamless human-machine interaction

Northern Dynasty Closes US$15 Million Convertible Notes Offering and CAD$3.4 Million Private Placement

ACCESSWIRE

2 years ago

Northern Dynasty Closes US$15 Million Convertible Notes Offering and CAD$3.4 Million Private Placement

BioRestorative Therapies Receives a Notice of Allowance by the United States Patent and Trademark Office for a Patent Application Related to its Obesity Program

GlobeNewswire

2 years ago

BioRestorative Therapies Receives a Notice of Allowance by the United States Patent and Trademark Office for a Patent Application Related to its Obesity Program

Onconova Therapeutics’ Preclinical Narazaciclib Data at SABCS Highlights Differentiated Anti-Tumor Activity v. Other CDK4/6i’s

GlobeNewswire

2 years ago

Onconova Therapeutics’ Preclinical Narazaciclib Data at SABCS Highlights Differentiated Anti-Tumor Activity v. Other CDK4/6i’s

Momentus Mission Update

Business Wire

2 years ago

Momentus Mission Update

Express (EXPR) Q3 2023 Earnings Call Transcript

Motley Fool

2 years ago

Express (EXPR) Q3 2023 Earnings Call Transcript

Sangoma to Showcase Innovations at Benchmark Discovery One-on-One Conference in New York

Business Wire

2 years ago

Sangoma to Showcase Innovations at Benchmark Discovery One-on-One Conference in New York

New Real-World Data Highlight the Clinical Benefits of Ultrafiltration Therapy with Hematocrit Monitoring for Pediatric Patients

GlobeNewswire

2 years ago

New Real-World Data Highlight the Clinical Benefits of Ultrafiltration Therapy with Hematocrit Monitoring for Pediatric Patients

Ocuphire Pharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

2 years ago

Ocuphire Pharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

5 REITs With Recent Insider Buying

Benzinga

2 years ago

5 REITs With Recent Insider Buying

Phoenix Wins Contract Under Florida Sheriffs Association Cooperative Purchasing Program for Electric School Buses

ACCESSWIRE

2 years ago

Phoenix Wins Contract Under Florida Sheriffs Association Cooperative Purchasing Program for Electric School Buses

Thomson Reuters StreetEvents

2 years ago

Q3 2023 Symbotic Inc Earnings Call

Symbotic Inc. (NASDAQ:SYM) Q4 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Symbotic Inc. (NASDAQ:SYM) Q4 2023 Earnings Call Transcript

Professional Diversity Network Third Quarter 2023 Earnings: US$0.12 loss per share (vs US$0.11 loss in 3Q 2022)

Simply Wall St.

2 years ago

Professional Diversity Network Third Quarter 2023 Earnings: US$0.12 loss per share (vs US$0.11 loss in 3Q 2022)

Favourable Signals For OLB Group: Numerous Insiders Acquired Stock

Simply Wall St.

2 years ago

Favourable Signals For OLB Group: Numerous Insiders Acquired Stock

Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

2 years ago

Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

OLB Group to Conduct Second Quarter Earnings Call November 15

ACCESSWIRE

2 years ago

OLB Group to Conduct Second Quarter Earnings Call November 15

The Dixie Group, Inc. (NASDAQ:DXYN) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

The Dixie Group, Inc. (NASDAQ:DXYN) Q3 2023 Earnings Call Transcript

Allied Gaming & Entertainment Inc. (NASDAQ:AGAE) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Allied Gaming & Entertainment Inc. (NASDAQ:AGAE) Q3 2023 Earnings Call Transcript

Origin Materials, Inc. Reports Operating and Financial Results for Third Quarter 2023

Business Wire

2 years ago

Origin Materials, Inc. Reports Operating and Financial Results for Third Quarter 2023

NeurAxis Signs Exclusive Option Agreement with University of Michigan for Innovative Gastrointestinal Device

GlobeNewswire

2 years ago

NeurAxis Signs Exclusive Option Agreement with University of Michigan for Innovative Gastrointestinal Device

Nuwellis, Inc. Announces Third Quarter 2023 Financial Results

GlobeNewswire

2 years ago

Nuwellis, Inc. Announces Third Quarter 2023 Financial Results

Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA

GlobeNewswire

2 years ago

Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA

Steven J. Pully Appointed to Enzo Biochem’s Board of Directors

GlobeNewswire

2 years ago

Steven J. Pully Appointed to Enzo Biochem’s Board of Directors

Share on Social Networks: